Lecture Details - Overview

View all Online CME

Continuing Education Information

Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Emerging Trends in Oncology: Lung Cancer & Novel Agents

Release Date: August 18, 2008| Expiration Date: August 18, 2009
Jun 13-Jul 26, 2008, Atlanta, GA and Philadelphia, PA

Lecture Overview

The Emerging Trends in Oncology: Lung Cancer & Novel Agents activity is an on-demand webcast  representing  the most highly-rated live presentations from a series of 1-day seminars designed to present practicing medical, surgical, and radiation oncologists; hematologists; nurses; and other clinicians with a synthesis of key data presented at the 2008 major national oncology conferences. This activity has been designed to update physicians on recent advances and new treatment modalities in the management of thoracic malignancies and novel agents. Online publication provides availability of key data to locoregional practicing physicians by leading faculty who present recommendations about clinical challenges faced in the daily management of patients with thoracic malignancies as well as notable novel agents.

This educational activity is intended for medical, surgical, and radiation oncologists; hematologists; and fellows practicing in the community or academic institutions. Nurses, physician assistants, and other individuals interested in the treatment of lung cancer are also invited to participate.

Lung Cancer

  • Analyze recent data on cytotoxic and targeted approaches, including antiangiogenic and anti-EGFR agents, to lung cancer therapy
  • Discuss clinical outcomes with doublet chemotherapy compared to doublet chemotherapy followed by consolidation with a third cytotoxic agent
  • Evaluate the role of antiangiogenic agents in treating recurrent glioblastoma

Instructions for Participation

To view the streaming Flash Video lectures, click the "View Flash Presentation" link. The latest version of Flash Player is recommended to view the Flash video.
Click here to download Flash Player >>

To download Podcast-ready movies, click "Download Video Podcast," and select "Save target as..." The latest version of Quicktime is recommended to view these movies.
Click here to download Quicktime >>

View the Activity
You will be asked to login
or create an account.

Educational Grants

An educational grant for this activity was provided by:


  1. Novartis Oncology
  2. Genentech BioOncology
  3. sanofi-aventis U.S.
  4. Celgene
  5. Bayer HealthCare Pharmaceuticals/
    Onyx Pharmaceuticals, Inc.
  6. Bristol-Myers Squibb/
    ImClone Systems